Next Article in Journal
Quality of Sugar Beets under the Effects of Digestate Application to the Soil
Next Article in Special Issue
Hot Melt Extrusion Processing Parameters Optimization
Previous Article in Journal
Modeling, Control, and Prediction of the Spread of COVID-19 Using Compartmental, Logistic, and Gauss Models: A Case Study in Iraq and Egypt
Previous Article in Special Issue
The Importance of Dose Intensity When Administering Cytotoxic Chemotherapy in NSCLC—A Matter as Actual Now as in the Past
 
 
Article
Peer-Review Record

Biological Evaluation of Azetidine-2-One Derivatives of Ferulic Acid as Promising Anti-Inflammatory Agents

Processes 2020, 8(11), 1401; https://doi.org/10.3390/pr8111401
by Maria Drăgan 1, Cătălina Daniela Stan 1,*, Andreea Teodora Iacob 2, Oana Maria Dragostin 3, Mihaela Boancă 4, Cătălina Elena Lupuşoru 4, Carmen Lăcrămioara Zamfir 5 and Lenuţa Profire 2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Processes 2020, 8(11), 1401; https://doi.org/10.3390/pr8111401
Submission received: 22 September 2020 / Revised: 27 October 2020 / Accepted: 30 October 2020 / Published: 2 November 2020
(This article belongs to the Special Issue Pharmaceutical Development and Bioavailability Analysis)

Round 1

Reviewer 1 Report

Some comments:

The authors used Swiss whit mice for toxicity test, while using rat for inflammation test. Although mice and rat look similar but the toxicity cannot be fully translated. Please justify.

 

The authors has include proper positive controls in their studies (Indomethacin and diclofenac sodium), it is good that the authors can label clearly in their figures and legends that the concentrations of all tested compounds they used in each test.

The authors claimed that the derivatives of ferulic acid are potent anti-inflammatory agents, but I don't think it is potent when compared with Indomethacin they used as positive control. Please consider to refine some better description.

For figure 4b, the power of resolution seems different from other similar figures, please check.

The authors has published some in vitro results, I suggest they should mention in the introduction, based on their in vitro findings and extend to current animal study.

In the discussion, the authors should discuss some possible mechanism of action of the anti-inflammation activities of ferulic acid. Is it related NASID?

Author Response

Please see the attachment!

Author Response File: Author Response.docx

Reviewer 2 Report

Please consider the following recommendations:

  • the general structure for the compounds 6 (line 82) must be redrawn with a larger fonts for the atoms
  • nocardicins and monobactams (line 75), are the same subclass of beta-lactam antibiotics. There are no two different classes. 
  • there is only one sulbactam and only one tazobactam. No sulbactams and tazobactams (line 75)

Author Response

Please see the attachment!

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

No further comments.

Back to TopTop